Viewing Study NCT00833859


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-01-22 @ 10:53 AM
Study NCT ID: NCT00833859
Status: TERMINATED
Last Update Posted: 2017-10-09
First Post: 2009-01-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stereotactic radiosurgery View
None borderline resectable pancreatic cancer View
None gastrointestinal View
None pancreas View